Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Keygesic-10
2. Magan
3. Mobidin
4. Momentum (magnesium Salicylate)
1. 18917-89-0
2. Magnesium Disalicylate
3. Magnesiumsalicylate
4. Magan
5. Magnesium Salicylate Anhydrous
6. Jq69d454n1
7. Mobidin
8. Magnesium, Bis[2-(hydroxy-.kappa.o)benzoato-.kappa.o]-, (t-4)-
9. Backache Relief
10. Chebi:6640
11. Bis(salicylato)magnesium; Magan; Magnesium Bis(salicylate); Salicylic Acid, Magnesium Salt
12. Bis(salicylato)magnesium
13. Magnesium Bis(salicylate)
14. Unii-jq69d454n1
15. Magnesium, Bis(2-(hydroxy-.kappa.o)benzoato-.kappa.o)-, (t-4)-
16. Einecs 242-669-3
17. Analate
18. Lorisal
19. Triact
20. Salicylic Acid, Magnesium Salt (2:1)
21. Magnesium;2-carboxyphenolate
22. Schembl9981
23. Chembl2106755
24. Dtxsid00889392
25. Magnesium Salicylate [mi]
26. Magnesium Salicylate (1:2)
27. Akos015901813
28. Db01397
29. Magnesium, Bis(2-hydroxybenzoato-o1,o2)-
30. Q6731407
Molecular Weight | 298.53 g/mol |
---|---|
Molecular Formula | C14H10MgO6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 298.0327797 g/mol |
Monoisotopic Mass | 298.0327797 g/mol |
Topological Polar Surface Area | 121 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 133 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Magnesium salicylate is a common analgesic and non-steroidal anti-inflammatory drug (NSAID) used to treat mild to moderate muscular pain
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
Most NSAIDs act as nonselective inhibitors of the enzyme cyclooxygenase (COX), inhibiting both the cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) isoenzymes. COX catalyzes the formation of prostaglandins and thromboxane from arachidonic acid (itself derived from the cellular phospholipid bilayer by phospholipase A2). Prostaglandins act (among other things) as messenger molecules in the process of inflammation.
Related Excipient Companies
Excipients by Applications
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A magnesium;2-carboxyphenolate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of magnesium;2-carboxyphenolate, including repackagers and relabelers. The FDA regulates magnesium;2-carboxyphenolate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. magnesium;2-carboxyphenolate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of magnesium;2-carboxyphenolate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A magnesium;2-carboxyphenolate supplier is an individual or a company that provides magnesium;2-carboxyphenolate active pharmaceutical ingredient (API) or magnesium;2-carboxyphenolate finished formulations upon request. The magnesium;2-carboxyphenolate suppliers may include magnesium;2-carboxyphenolate API manufacturers, exporters, distributors and traders.
click here to find a list of magnesium;2-carboxyphenolate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A magnesium;2-carboxyphenolate DMF (Drug Master File) is a document detailing the whole manufacturing process of magnesium;2-carboxyphenolate active pharmaceutical ingredient (API) in detail. Different forms of magnesium;2-carboxyphenolate DMFs exist exist since differing nations have different regulations, such as magnesium;2-carboxyphenolate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A magnesium;2-carboxyphenolate DMF submitted to regulatory agencies in the US is known as a USDMF. magnesium;2-carboxyphenolate USDMF includes data on magnesium;2-carboxyphenolate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The magnesium;2-carboxyphenolate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of magnesium;2-carboxyphenolate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing magnesium;2-carboxyphenolate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for magnesium;2-carboxyphenolate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture magnesium;2-carboxyphenolate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain magnesium;2-carboxyphenolate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a magnesium;2-carboxyphenolate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of magnesium;2-carboxyphenolate suppliers with NDC on PharmaCompass.
magnesium;2-carboxyphenolate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of magnesium;2-carboxyphenolate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right magnesium;2-carboxyphenolate GMP manufacturer or magnesium;2-carboxyphenolate GMP API supplier for your needs.
A magnesium;2-carboxyphenolate CoA (Certificate of Analysis) is a formal document that attests to magnesium;2-carboxyphenolate's compliance with magnesium;2-carboxyphenolate specifications and serves as a tool for batch-level quality control.
magnesium;2-carboxyphenolate CoA mostly includes findings from lab analyses of a specific batch. For each magnesium;2-carboxyphenolate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
magnesium;2-carboxyphenolate may be tested according to a variety of international standards, such as European Pharmacopoeia (magnesium;2-carboxyphenolate EP), magnesium;2-carboxyphenolate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (magnesium;2-carboxyphenolate USP).
LOOKING FOR A SUPPLIER?